All In Biotech

Drug Trial Radar · NCT00970489

Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation

(OPERA)Randomized Clinical Trial to Examine Whether Peri-operative Intake of n-3 Polyunsaturated Fatty Acids Will Reduce the Occurrence of Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

Last checked: Nov 20, 2026Latest source record: Apr 10, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,516 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,516

Actual

Start

Aug 2010

Primary completion

May 2012

Study completion Jun 2012

Sponsor

Lead sponsor
Brigham and Women's HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The OPERA Investigators
First posted
Sep 2, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a large multi-center study to examine whether peri-operative intake of n-3 polyunsaturated fatty acids (PUFA) will reduce the occurrence of post-operative atrial fibrillation or flutter (AF) in patients undergoing cardiac surgery (CS).

Conditions

  • Atrial Fibrillation

Interventions

  • Omega -3 fatty acidsDrug

    10g dose of oral omega-3 fatty acid capsules over 3-5 days before surgery (or 8 g over 2 days before surgery), including the morning of surgery, followed by 2g/d after surgery for 10 days, or until discharge, whichever occurs first.

  • PlaceboDrug

    Olive Oil capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Any First Post-op Atrial Fibrillation or Flutter (AF)Time frame: up to 10 days post-surgery or discharge, whichever sooner

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • US, Italy and Argentina

    Boston, Massachusetts

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.